EGRX logo

Eagle Pharmaceuticals (EGRX) Total Debt

Annual Total Debt

$62.47 M
+$35.55 M+132.08%

December 31, 2022


Summary


Performance

EGRX Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEGRXbalance sheetmetrics:

Quarterly Total Debt

$71.61 M
-$6.30 M-8.09%

June 30, 2023


Summary


Performance

EGRX Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEGRXbalance sheetmetrics:

Total Debt Formula

Total Debt = Short Term Debt + Long Term Debt

EGRX Total Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+132.1%+33.6%
3 y3 years+50.3%+77.4%
5 y5 years+30.7%+53.3%

EGRX Total Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+132.1%-8.1%+166.1%
5 y5-yearat high+132.1%-52.7%+166.1%
alltimeall timeat high-100.0%-52.7%-100.0%

Eagle Pharmaceuticals Total Debt History

DateAnnualQuarterly
Jun 2023
-
$71.61 M(-8.1%)
Mar 2023
-
$77.92 M(+21.7%)
Dec 2022
$62.47 M(+132.1%)
$64.00 M(-1.2%)
Sep 2022
-
$64.77 M(+20.9%)
Jun 2022
-
$53.59 M(+94.0%)
Mar 2022
-
$27.63 M(+2.6%)
Dec 2021
$26.92 M(-21.4%)
$26.92 M(-15.2%)
Sep 2021
-
$31.74 M(-6.4%)
Jun 2021
-
$33.91 M(-6.0%)
Mar 2021
-
$36.06 M(+5.3%)
Dec 2020
$34.26 M(-17.6%)
$34.26 M(-12.1%)
Sep 2020
-
$38.98 M(-3.4%)
Jun 2020
-
$40.37 M(-73.4%)
Mar 2020
-
$151.50 M(+264.6%)
Dec 2019
$41.56 M(-6.4%)
$41.56 M(-5.5%)
Sep 2019
-
$44.00 M(+1.3%)
Jun 2019
-
$43.45 M(+3.5%)
Mar 2019
-
$42.00 M(-5.4%)
Dec 2018
$44.41 M(-7.1%)
$44.41 M(+0.2%)
Sep 2018
-
$44.31 M(-5.2%)
Jun 2018
-
$46.72 M(-2.4%)
Mar 2018
-
$47.87 M(+0.2%)
DateAnnualQuarterly
Dec 2017
$47.78 M(>+9900.0%)
$47.78 M(-2.4%)
Sep 2017
-
$48.94 M(>+9900.0%)
Jun 2017
-
$0.00(0.0%)
Mar 2017
-
$0.00(0.0%)
Dec 2016
$0.00(0.0%)
$0.00(0.0%)
Sep 2016
-
$0.00(0.0%)
Jun 2016
-
$0.00(0.0%)
Mar 2016
-
$0.00(0.0%)
Dec 2015
$0.00(0.0%)
$0.00(0.0%)
Sep 2015
-
$0.00(0.0%)
Jun 2015
-
$0.00(0.0%)
Mar 2015
-
$0.00(0.0%)
Dec 2014
-
$0.00(0.0%)
Sep 2014
$0.00(0.0%)
$0.00(0.0%)
Jun 2014
-
$0.00(0.0%)
Mar 2014
-
$0.00(0.0%)
Dec 2013
-
$0.00(0.0%)
Sep 2013
$0.00(-100.0%)
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
Mar 2013
-
$0.00(0.0%)
Dec 2012
-
$0.00
Sep 2012
$8.57 M
-

FAQ

  • What is Eagle Pharmaceuticals annual total debt?
  • What is the all time high annual total debt for Eagle Pharmaceuticals?
  • What is Eagle Pharmaceuticals annual total debt year-on-year change?
  • What is Eagle Pharmaceuticals quarterly total debt?
  • What is the all time high quarterly total debt for Eagle Pharmaceuticals?
  • What is Eagle Pharmaceuticals quarterly total debt year-on-year change?

What is Eagle Pharmaceuticals annual total debt?

The current annual total debt of EGRX is $62.47 M

What is the all time high annual total debt for Eagle Pharmaceuticals?

Eagle Pharmaceuticals all-time high annual total debt is $62.47 M

What is Eagle Pharmaceuticals annual total debt year-on-year change?

Over the past year, EGRX annual total debt has changed by +$35.55 M (+132.08%)

What is Eagle Pharmaceuticals quarterly total debt?

The current quarterly total debt of EGRX is $71.61 M

What is the all time high quarterly total debt for Eagle Pharmaceuticals?

Eagle Pharmaceuticals all-time high quarterly total debt is $151.50 M

What is Eagle Pharmaceuticals quarterly total debt year-on-year change?

Over the past year, EGRX quarterly total debt has changed by +$18.02 M (+33.63%)